Craft
Neovii

Neovii

Neovii Summary

Company summary

Overview
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology. Its product Grafalon is used in immunosuppressive therapies for the prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation, and in treatment of aplastic anemia.
Type
Private
Founded
2003
HQ
Rapperswil-Jona, CH | view all locations
Website
https://neovii.com
Cybersecurity rating
Sectors

Key people

  • Jürgen Pohle

    Jürgen Pohle, Chief Executive Officer and General Manager

    • Alfred Doucette

      Alfred Doucette, Chief Financial Officer

      • Christian Loss

        Christian Loss, CEO

        LocationsView all

        4 locations detected

        • Rapperswil-Jona, SG HQ

          Switzerland

          Zürcherstrasse 19

        • Lexington, MA

          United States

          430 Bedford St #195

        • Gräfelfing, BY

          Germany

          Am Haag 6

        • İstanbul

          Turkey

          Ataşehir Atatürk, Ataşehir Blv. No:5 D:10d

        News

        Footer menu